Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Paul Edward Kelly

COO at Relmada Therapeutics, Inc. (RLMD)

Purchase track record

Not enough history. Based on 1 purchase with a full 90 days of price history.

—
Avg. 90-day return+39.8%
vs. S&P 500+37.2%
Beat the market100%
Paper profit on buys+$107K
Total bought / sold$198K / $0

Reported trades

Filed Stock Type Shares Price Value Since
Nov 6SEC RLMDRelmada Therapeutics, Inc. Buy 90,000502,295 held (+22%) $2.20 $198K +54.1%
  • Buy

    COO Paul Edward Kelly bought $198K of RLMD at $2.20 — first open-market purchase in our records; raises the stake by 22%.